Home
>
Integrated Licensing
>
Hellsinn's Product Pipeline
> ST-1141
Orally available, for the treatment of opioid-induced bowel dysfunction
In phase I stage
Helsinn owns the worldwide rights of development and commercialization
Copyright © Helsinn Group - Legal Statement
